Article

Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal…

Sarcoma · 2012 · Noah Federman, author Jason Chan, author Jon O. Nagy, author Elliot M. Landaw, author Katelyn McCabe, author Anna M. Wu, author Timothy Triche, author HyungGyoo Kang, author Bin Liu, author James D. Marks, author Christopher T. Denny, author Norman Jaffe, Academic Editor

Key facts

Title Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor
First author Noah Federman, author Jason Chan, author Jon O. Nagy, author Elliot M. Landaw, author Katelyn McCabe, author Anna M. Wu, author Timothy Triche, author HyungGyoo Kang, author Bin Liu, author James D. Marks, author Christopher T. Denny, author Norman Jaffe, Academic Editor
Journal Sarcoma
Published Jun 5, 2012
DOI 10.1155/2012/126906
Devices mentioned K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967, K923274 and 12 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JLX, KKX, KQP

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature